Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

315 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections.
Ahmed MIM, Diepers P, Janke C, Plank M, Eser TM, Rubio-Acero R, Fuchs A, Baranov O, Castelletti N, Kroidl I, Olbrich L, Bauer B, Wang D, Prelog M, Liese JG, Reinkemeyer C, Hoelscher M, Steininger P, Überla K, Wieser A, Geldmacher C. Ahmed MIM, et al. Among authors: hoelscher m. Front Immunol. 2022 Dec 13;13:1026473. doi: 10.3389/fimmu.2022.1026473. eCollection 2022. Front Immunol. 2022. PMID: 36582222 Free PMC article.
Integrative modelling of reported case numbers and seroprevalence reveals time-dependent test efficiency and infectious contacts.
Contento L, Castelletti N, Raimúndez E, Le Gleut R, Schälte Y, Stapor P, Hinske LC, Hoelscher M, Wieser A, Radon K, Fuchs C, Hasenauer J; KoCo19 study group. Contento L, et al. Among authors: hoelscher m. Epidemics. 2023 Jun;43:100681. doi: 10.1016/j.epidem.2023.100681. Epub 2023 Mar 11. Epidemics. 2023. PMID: 36931114 Free PMC article.
Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S.
Ahmed MIM, Plank M, Castelletti N, Diepers P, Eser TM, Rubio-Acero R, Noreña I, Reinkemeyer C, Zapf D, Hoelscher M, Janke C, Wieser A, Geldmacher C, On Behalf Of The KoCo/Orchestra Study Group. Ahmed MIM, et al. Among authors: hoelscher m. Diagnostics (Basel). 2023 Mar 8;13(6):1024. doi: 10.3390/diagnostics13061024. Diagnostics (Basel). 2023. PMID: 36980332 Free PMC article.
Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion.
Eser TM, Baranov O, Huth M, Ahmed MIM, Deák F, Held K, Lin L, Pekayvaz K, Leunig A, Nicolai L, Pollakis G, Buggert M, Price DA, Rubio-Acero R, Reich J, Falk P, Markgraf A, Puchinger K, Castelletti N, Olbrich L, Vanshylla K, Klein F, Wieser A, Hasenauer J, Kroidl I, Hoelscher M, Geldmacher C. Eser TM, et al. Among authors: hoelscher m. Nat Commun. 2023 May 24;14(1):2952. doi: 10.1038/s41467-023-38020-8. Nat Commun. 2023. PMID: 37225706 Free PMC article.
Incidence and Determinants of Symptomatic and Asymptomatic SARS-CoV-2 Breakthrough Infections After Booster Dose in a Large European Multicentric Cohort of Health Workers-ORCHESTRA Project.
Porru S, Monaco MGL, Spiteri G, Carta A, Caliskan G, Violán C, Torán-Monserrat P, Vimercati L, Tafuri S, Boffetta P, Violante FS, Sala E, Sansone E, Gobba F, Casolari L, Wieser A, Janke C, Tardon A, Rodriguez-Suarez MM, Liviero F, Scapellato ML, dell'Omo M, Murgia N, Mates D, Calota VC, Strhársky J, Mrázová M, Pira E, Godono A, Magnano GC, Negro C, Verlato G; Orchestra WP5 Working Group. Porru S, et al. J Epidemiol Glob Health. 2023 Sep;13(3):577-588. doi: 10.1007/s44197-023-00139-8. Epub 2023 Jul 22. J Epidemiol Glob Health. 2023. PMID: 37480426 Free PMC article.
Impact of the COVID-19 pandemic on people in need of care or support: protocol for a SARS-CoV-2 registry.
Gensichen J, Zöllinger I, Gagyor I, Hausen A, Hölscher M, Janke C, Kühlein T, Nassehi A, Teupser D, Arend FM, Eidenschink C, Hindenburg D, Kosub H, Kurotschka PK, Lindemann D, Mayr K, Müller S, Rink L, Rottenkolber M, Sanftenberg L, Schwaiger R, Sebastião M, Wildgruber D, Dreischulte T; BaCoM Study group. Gensichen J, et al. BMJ Open. 2023 May 16;13(5):e071134. doi: 10.1136/bmjopen-2022-071134. BMJ Open. 2023. PMID: 37192790 Free PMC article.
Distinct and dynamic activation profiles of circulating dendritic cells and monocytes in mild COVID-19 and after yellow fever vaccination.
Winheim E, Eser T, Deák F, Ahmed MIM, Baranov O, Rinke L, Eisenächer K, Santos-Peral A, Karimzadeh H, Pritsch M, Scherer C, Muenchhoff M, Hellmuth JC, von Bergwelt-Baildon M, Olbrich L, Hoelscher M, Wieser A, Kroidl I, Rothenfusser S, Geldmacher C, Krug AB. Winheim E, et al. Among authors: hoelscher m. Eur J Immunol. 2023 Mar;53(3):e2250090. doi: 10.1002/eji.202250090. Epub 2022 Dec 9. Eur J Immunol. 2023. PMID: 36404054 Free article.
Clinical and immunological benefits of full primary COVID-19 vaccination in individuals with SARS-CoV-2 breakthrough infections: A prospective cohort study in non-hospitalized adults.
Prelog M, Jeske SD, Asam C, Fuchs A, Wieser A, Gall C, Wytopil M, Mueller-Schmucker SM, Beileke S, Goekkaya M, Kling E, Geldmacher C, Rubio-Acero R, Plank M, Christa C, Willmann A, Vu M, Einhauser S, Weps M, Lampl BMJ, Almanzar G, Kousha K, Schwägerl V, Liebl B, Weber B, Drescher J, Scheidt J, Gefeller O, Messmann H, Protzer U, Liese J, Hoelscher M, Wagner R, Überla K, Steininger P; CoVaKo Study Group. Prelog M, et al. Among authors: hoelscher m. J Clin Virol. 2024 Feb;170:105622. doi: 10.1016/j.jcv.2023.105622. Epub 2023 Nov 28. J Clin Virol. 2024. PMID: 38091664
Persistent immune abnormalities discriminate post-COVID syndrome from convalescence.
Sbierski-Kind J, Schlickeiser S, Feldmann S, Ober V, Grüner E, Pleimelding C, Gilberg L, Brand I, Weigl N, Ahmed MIM, Ibarra G, Ruzicka M, Benesch C, Pernpruner A, Valdinoci E, Hoelscher M, Adorjan K, Stubbe HC, Pritsch M, Seybold U, Roider J; Post COVID Care and KoCo19 study groups. Sbierski-Kind J, et al. Among authors: hoelscher m. Infection. 2024 Feb 7. doi: 10.1007/s15010-023-02164-y. Online ahead of print. Infection. 2024. PMID: 38326527
315 results